Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Both invariant natural killer T (NK T) cells and CD4(+)CD25(+) T regulatory cells (T(regs)) regulate the immune system to maintain homeostasis. In a tumour setting, NK T cells activated by alpha-galactosylceramide (alpha-GalCer) execute anti-tumour activity by secreting cytokines. By contrast, T(regs) intrinsically suppress antigen-specific immune responses and are often found to be elevated in tumour patients. In this study, we have shown that T(regs) regulate NK T cell function negatively in vitro, suggesting a direct interaction between these cell types. In a murine mammary tumour model, we demonstrated that administration of either alpha-GalCer or anti-CD25 antibody alone markedly suppressed tumour formation and pulmonary metastasis, and resulted in an increase in the survival rate up to 44% (from a baseline of 0%). When treatments were combined, depletion of T(regs) boosted the anti-tumour effect of alpha-GalCer, and the survival rate jumped to 85%. Our results imply a potential application of combining T(reg) cell depletion with alpha-GalCer to stimulate NK T cells for cancer therapy.

Original publication

DOI

10.1111/j.1365-2249.2009.04018.x

Type

Journal article

Journal

Clin Exp Immunol

Publication Date

01/2010

Volume

159

Pages

93 - 99

Keywords

Animals, Antibodies, Monoclonal, Dendritic Cells, Disease Models, Animal, Female, Galactosylceramides, Immunity, Cellular, Interferon-gamma, Interleukin-2 Receptor alpha Subunit, Lung Neoplasms, Lymphocyte Activation, Lymphocyte Depletion, Mammary Neoplasms, Experimental, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Natural Killer T-Cells, Survival Rate, T-Lymphocytes, Regulatory